Cytognos has developed an anti-human CD38 multi-epitope reagent containing a mixture of antibodies that allows the identification by flow cytometry of CD38 molecule on plasma cells, even in patients under anti-CD38 therapy.
Comparative evaluation by flow cytometry of CD38-FITC monoclonal (dark grey dots) and CD38-FITC multi-epitope (CYT-38F2; red dots) performance. A) Bone marrow sample from untreated patient. B) Patient treated with therapy 1. C) Patient treated with therapy 2.